GIP and type 2 diabetes mellitus: While treatment with GLP-1 potently amplifies GSIS in patients with T2DM, GIP treatment fails to do so; despite the fact that receptors of both of these hormones couple to Gαs to stimulate intracellular cAMP-dependent signaling.